Published in J Med Virol on May 01, 1993
Hepatitis A: old and new. Clin Microbiol Rev (2001) 1.82
Diagnosis of hepatitis a virus infection: a molecular approach. Clin Microbiol Rev (2006) 1.42
Recombinant hepatitis A virus antigen: improved production and utility in diagnostic immunoassays. J Clin Microbiol (1998) 0.79
Immune response to hepatitis A virus capsid proteins after infection. J Clin Microbiol (1996) 0.78
Development of a peptide ELISA to discriminate vaccine-induced immunity from natural infection of hepatitis A virus in a phase IV study. Eur J Clin Microbiol Infect Dis (2017) 0.75
The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med (1999) 16.35
Evidence for virus-specific noncapsid proteins in poliovirus-infected HeLa cells. Proc Natl Acad Sci U S A (1965) 11.84
The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med (1992) 9.10
A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1. Antimicrob Agents Chemother (2000) 8.54
Evidence for large precursor proteins in poliovirus synthesis. Proc Natl Acad Sci U S A (1968) 8.24
Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science (2000) 6.73
The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA (1990) 6.09
Classification of rhabdovirus proteins: a proposal. J Virol (1972) 5.54
An outbreak of influenza aboard a commercial airliner. Am J Epidemiol (1979) 5.51
Protein synthesis in vesicular stomatitis virus-infected HeLa cells. Virology (1970) 5.14
Polysomal ribonucleic acid of vesicular stomatitis virus-infected HeLa cells. Virology (1970) 4.85
Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. Proc Natl Acad Sci U S A (1993) 4.11
Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. N Engl J Med (1998) 3.81
Identification of a Kunjin/West Nile-like flavivirus in brains of patients with New York encephalitis. Lancet (1999) 3.80
Translation of poliovirus RNA in vitro: changes in cleavage pattern and initiation sites by ribosomal salt wash. Virology (1979) 3.61
Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health (1999) 3.55
The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology (2000) 3.53
Membrane rearrangement and vesicle induction by recombinant poliovirus 2C and 2BC in human cells. Virology (1994) 3.52
Plus and minus strand leader RNAs in negative strand virus-infected cells. Cell (1979) 3.50
Poly (rC) binding protein 2 forms a ternary complex with the 5'-terminal sequences of poliovirus RNA and the viral 3CD proteinase. RNA (1997) 3.47
The decrease in size and synthetic activity of poliovirus polysomes late in the infectious cycle. Virology (1967) 3.41
Requirement of poly(rC) binding protein 2 for translation of poliovirus RNA. J Virol (1997) 3.40
Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA (1989) 3.39
Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex. J Virol (1988) 3.28
Gene expression profiling of cells, tissues, and developmental stages of the nematode C. elegans. Cold Spring Harb Symp Quant Biol (2003) 3.22
Genetic analysis of West Nile New York 1999 encephalitis virus. Lancet (1999) 3.12
A multistate, foodborne outbreak of hepatitis A. National Hepatitis A Investigation Team. N Engl J Med (1999) 3.09
Double-stranded poliovirus RNA inhibits initiation of protein synthesis by reticulocyte lysates. Proc Natl Acad Sci U S A (1971) 2.99
Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. Sentinel Counties Viral Hepatitis Study Team. N Engl J Med (1997) 2.90
A transmembrane guanylyl cyclase (DAF-11) and Hsp90 (DAF-21) regulate a common set of chemosensory behaviors in caenorhabditis elegans. Genetics (2000) 2.90
Poly(rC) binding protein 2 binds to stem-loop IV of the poliovirus RNA 5' noncoding region: identification by automated liquid chromatography-tandem mass spectrometry. Proc Natl Acad Sci U S A (1996) 2.82
Determination of the gene sequence of poliovirus with pactamycin. Proc Natl Acad Sci U S A (1971) 2.80
Isolation of a viral polypeptide associated with poliovirus RNA polymerase. Proc Natl Acad Sci U S A (1974) 2.79
Genetic relatedness of hepatitis A virus strains recovered from different geographical regions. J Gen Virol (1992) 2.74
The diverse patterns of hepatitis A epidemiology in the United States-implications for vaccination strategies. J Infect Dis (1998) 2.68
Incidence of hepatitis B virus infection in the United States, 1976-1994: estimates from the National Health and Nutrition Examination Surveys. J Infect Dis (1998) 2.67
Translation of poliovirus RNA in vitro: detection of two different initiation sites. J Mol Biol (1975) 2.58
In vitro assembly of poliovirus-related particles. Virology (1968) 2.55
Contribution of increasing CO2 and climate to carbon storage by ecosystems in the United States. Science (2000) 2.51
BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene (1998) 2.39
Partial structural analysis of the oligosaccharide moieties of the vesicular stomatitis virus glycoprotein by sequential chemical and enzymatic degradation. Virology (1977) 2.36
Relationship of p220 cleavage during picornavirus infection to 2A proteinase sequencing. J Virol (1988) 2.32
Control of protein synthesis in extracts from poliovirus-infected cells. I. mRNA discrimination by crude initiation factors. J Virol (1978) 2.31
Specific changes in the oligosaccharide moieties of VSV grown in different lectin-resistnat CHO cells. Cell (1978) 2.30
An internal 5'-noncoding region required for translation of poliovirus RNA in vitro. J Virol (1988) 2.29
Oligosaccharide chains are trimmed during synthesis of the envelope glycoprotein of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1978) 2.29
Purification and properties of HeLa cell plasma membranes. J Biol Chem (1971) 2.29
Soluble RNA polymerase complex from poliovirus-infected HeLa cells. Virology (1970) 2.26
Evidence for differences in size and composition of the poliovirus-specific polypeptides in infected HeLa cells. Virology (1968) 2.23
Characterization of ribonuclease-resistant RNA from poliovirus-infected HeLa cells. Proc Natl Acad Sci U S A (1965) 2.22
Interactions of vesicular stomatitis virus structural proteins with HeLa plasma membranes. Nat New Biol (1971) 2.19
Molecular characterization of two mammalian bHLH-PAS domain proteins selectively expressed in the central nervous system. Proc Natl Acad Sci U S A (1997) 2.15
Formation of the poliovirus replication complex requires coupled viral translation, vesicle production, and viral RNA synthesis. J Virol (2000) 2.13
Poliovirus 2C protein determinants of membrane binding and rearrangements in mammalian cells. J Virol (1997) 2.13
Assembly of vesicular stomatitis virus glycoprotein and matrix protein into HeLa cell plasma membranes. J Mol Biol (1976) 2.10
GIS-based measures of environmental equity: exploring their sensitivity and significance. J Expo Anal Environ Epidemiol (1999) 2.07
Phosphorylation of vesicular stomatitis virus in vivo and in vitro. J Virol (1974) 2.07
Glycosylation of vesicular stomatitis virus glycoprotein in virus-infected HeLa cells. J Virol (1976) 2.06
Inhibition of cleavage of large poliovirus-specific precursor proteins in infected HeLa cells by inhibitors of proteolytic enzymes. J Virol (1972) 2.06
Adenylate-rich sequences in vesicular stomatitis virus messenger ribonucleic acid. J Virol (1972) 2.05
Host factors related to poor immunogenicity of hepatitis B vaccine in adults. Another reason to immunize early. JAMA (1994) 2.03
Cleavage of the cap binding protein complex polypeptide p220 is not effected by the second poliovirus protease 2A. Virology (1986) 2.02
Differential utilization of poly(rC) binding protein 2 in translation directed by picornavirus IRES elements. RNA (1999) 2.00
Immune dysregulation in TGF-beta 1-deficient mice. J Immunol (1994) 2.00
Evidence for ambiguity in the posttranslational cleavage of poliovirus proteins. Virology (1970) 1.93
Untranslated vesicular stomatitis virus messenger RNA after poliovirus infection. Virology (1977) 1.92
Influenza A virus RNA polymerase subunit PB2 is the endonuclease which cleaves host cell mRNA and functions only as the trimeric enzyme. Virology (1995) 1.92
Sub-cellular localization of vesicular stomatitis virus messenger RNAs. Biochem Biophys Res Commun (1975) 1.91
In vitro synthesis of proteins by membrane-bound polyribosomes from vesicular stomatitis virus-infected HeLa cells. J Virol (1974) 1.90
Demonstration in vitro that eucaryotic initiation factor 3 is active but that a cap-binding protein complex is inactive in poliovirus-infected HeLa cells. J Virol (1984) 1.87
A multistate outbreak of hepatitis A caused by the consumption of raw oysters. Am J Public Health (1991) 1.85
Nosocomial transmission of hepatitis B virus associated with the use of a spring-loaded finger-stick device. N Engl J Med (1992) 1.85
Th size and shape of bacteria by light scattering measurements. Biochim Biophys Acta (1968) 1.85
In vitro protein synthetic activity of membrane-bound poliovirus polyribosomes. Virology (1971) 1.84
Requirement for transforming growth factor beta1 in controlling T cell apoptosis. J Exp Med (2001) 1.82
Screening for chronic hepatitis B and C virus infections in an urban sexually transmitted disease clinic: rationale for integrating services. Sex Transm Dis (2001) 1.81
Poliovirus-induced inhibition of host-cell protein synthesis. Cell (1982) 1.79
Poliovirus RNA replication. Curr Top Microbiol Immunol (1990) 1.78
Production and application of electron vortex beams. Nature (2010) 1.76
Alterations in initiation factor activity from poliovirus-infected HeLa cells. J Biol Chem (1979) 1.75
The cap-binding protein complex in uninfected and poliovirus-infected HeLa cells. J Biol Chem (1987) 1.73
Hepatitis E virus antibody prevalence among persons who work with swine. J Infect Dis (2001) 1.73
Cytoplasm from poliovirus-infected HeLa cells inhibits cell-free haemoglobin synthesis. Nat New Biol (1971) 1.72
Genetic and physiological analysis of conjugation in Streptococcus faecalis. J Bacteriol (1982) 1.72
Prevalence of antibody to hepatitis E virus among rodents in the United States. J Infect Dis (2000) 1.70
Cardiologists' practices compared with practice guidelines: use of beta-blockade after acute myocardial infarction. J Am Coll Cardiol (1995) 1.67
Serologic identification of hepatitis E virus infections in epidemic and endemic settings. J Med Virol (1992) 1.66
Constitution and function of polyribosomes of poliovirus-infected HeLa cells. Virology (1965) 1.65
Synthesis of plus- and minus-strand RNA from poliovirion RNA template in vitro. J Virol (1986) 1.60
Eukaryotic initiation factor 3 is required for poliovirus 2A protease-induced cleavage of the p220 component of eukaryotic initiation factor 4F. Proc Natl Acad Sci U S A (1990) 1.58
Association of vesicular stomatitis virus proteins with HeLa cell membranes and released virus. J Virol (1976) 1.57
Comparison of replication complexes synthesizing poliovirus RNA. Virology (1981) 1.55
The 5'-terminal nucleotides of hepatitis A virus RNA, but not poliovirus RNA, are required for infectivity. J Virol (1991) 1.55
Duration of viremia in hepatitis A virus infection. J Infect Dis (2000) 1.55
Haemophilus influenzae disease in Alaskan Eskimos: characteristics of a population with an unusual incidence of invasive disease. Lancet (1981) 1.53
Epidemiologic patterns of wild-type hepatitis A virus determined by genetic variation. J Infect Dis (1991) 1.53